Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SLQT
SLQT logo

SLQT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.688
Open
0.660
VWAP
0.66
Vol
2.34M
Mkt Cap
114.98M
Low
0.650
Amount
1.55M
EV/EBITDA(TTM)
12.17
Total Shares
176.29M
EV
760.65M
EV/OCF(TTM)
63.04
P/S(TTM)
0.08
SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.
Show More

Events Timeline

(ET)
2026-01-15
07:10:00
SelectQuote Reaches New Agreement with Long-Time PBM Partner
select
2025-08-21 (ET)
2025-08-21
07:37:32
SelectQuote Announces Q4 EPS of 2 Cents, Below Consensus Estimate of 13 Cents
select
2025-07-02 (ET)
2025-07-02
16:16:03
SelectQuote vice chairman Tom Grant passes away
select
2025-05-12 (ET)
2025-05-12
07:36:04
SelectQuote sees FY25 revenue $1.5B-$1.575B, consensus $1.53B
select
2025-05-12
07:35:24
SelectQuote reports Q3 EPS 3c vs 5c last year
select
2025-05-09 (ET)
2025-05-09
08:04:34
SelectQuote responds to allegations in DOJ complaint
select
2025-05-01 (ET)
2025-05-01
14:51:08
SelectQuote down 40% after U.S. files False Claims Act complaint
select

News

seekingalpha
9.5
02-05seekingalpha
SelectQuote Reports Strong Q2 2026 Earnings Amid Guidance Cuts
  • Strong Financial Performance: SelectQuote reported Q2 revenue of $537 million, a 12% year-over-year increase, with the Healthcare Services segment growing 26%, reflecting robust demand and execution in the senior market.
  • Record EBITDA Margins: The company achieved a near-record EBITDA margin of 39% in its Senior division, despite facing budget cuts from PBM and carrier partners, indicating strong profitability resilience.
  • Credit Facility Expansion: SelectQuote announced a new $415 million credit facility extending debt maturities to 2031, providing greater financial flexibility to support ongoing profitable growth initiatives.
  • Revised Financial Guidance: While management remains confident in long-term targets, the fiscal 2026 revenue guidance has been lowered to a range of $1.61 billion to $1.71 billion due to PBM and carrier budget cuts, highlighting short-term market challenges.
seekingalpha
9.5
02-05seekingalpha
SelectQuote Q2 Earnings Exceed Expectations
  • Earnings Beat: SelectQuote reported Q2 GAAP EPS of $0.26, exceeding expectations by $0.05, indicating strong profitability and boosting investor confidence in the company's financial health.
  • Revenue Growth: The company achieved revenue of $537.1 million, an 11.6% year-over-year increase, surpassing market expectations by $6.37 million, reflecting SelectQuote's competitive position and driving overall business growth.
  • Future Guidance: SelectQuote's guidance for fiscal year 2026 projects revenue between $1.61 billion and $1.71 billion, with adjusted EBITDA expected to range from $90 million to $100 million, showcasing the company's confidence in future growth and strategic planning.
  • Financing Support: The company secured a $415 million credit facility, extending debt maturity to 2031, which will provide greater financial flexibility and support its long-term growth strategy.
seekingalpha
9.5
02-04seekingalpha
SelectQuote Scheduled to Announce Q2 Earnings on February 5th
  • Earnings Announcement Date: SelectQuote (SLQT) is set to release its Q2 2023 earnings on February 5th before market open, with consensus EPS estimate at $0.28, reflecting a 6.7% year-over-year decline, while revenue is projected at $530.73 million, indicating a 10.3% year-over-year increase.
  • Performance Expectations: Over the past year, SelectQuote has exceeded EPS estimates 75% of the time and revenue estimates 100% of the time, demonstrating the company's reliability in performance forecasting, despite recent downward adjustments in both EPS and revenue estimates.
  • Revision Trends: In the last three months, SelectQuote's EPS estimates have seen no upward revisions and one downward revision, while revenue estimates have experienced four downward revisions, suggesting a cautious market outlook regarding the company's future performance.
  • Financing and Outlook: SelectQuote recently secured a $415 million credit facility, extending its debt maturity to 2031, and projects FY26 revenue between $1.65 billion and $1.75 billion, although it faces headwinds from pharmacy benefit managers (PBM).
Businesswire
8.5
01-12Businesswire
SelectQuote Secures $415 Million Credit Facility to Strengthen Financial Position
  • Successful Financing: SelectQuote has completed a new $415 million credit facility, consisting of a $325 million term loan and a $90 million revolving credit, significantly enhancing the company's liquidity and financial flexibility.
  • Debt Maturity Extension: This financing extends the company's debt maturity to 2031, allowing for better planning of future capital structure and investment strategies, further solidifying its leadership in the Medicare insurance market.
  • Cash Flow Validation: The confidence shown by Pathlight Capital and UMB Bank in this financing underscores SelectQuote's stability regarding its approximately $1 billion in commissions receivable and cash-generating capabilities, boosting investor confidence.
  • Management Confidence Boost: SelectQuote CEO Tim Danker stated that this financing marks a significant milestone in capital structure optimization, expected to support the company's continued growth in the senior health insurance and healthcare services sectors.
Globenewswire
7.0
2025-12-02Globenewswire
SelectQuote Faces Investigation Over Alleged Illegal Payments Exceeding $80 Million
  • Investigation Launched: Berman Tabacco announces an investigation into SelectQuote for allegedly receiving illegal payments from health insurers, potentially exceeding $80 million, highlighting significant governance risks within the company.
  • Details of Allegations: The complaint alleges that between 2016 and 2021, SelectQuote received illegal payments from Humana and Aetna to steer customers towards their Medicare offerings, revealing direct involvement from senior executives.
  • Stock Price Impact: Following the Department of Justice's complaint, SelectQuote's shares fell approximately 20%, indicating market concerns over corporate governance and compliance, which may lead to diminished investor confidence.
  • Board Accountability: The investigation will focus on whether SelectQuote's board had a role in the scheme and if its executives breached fiduciary duties, potentially impacting future management decisions and the company's reputation.
Newsfilter
7.0
2025-11-24Newsfilter
SelectQuote Under Investigation for Alleged Illegal Payments Exceeding $80 Million
  • Investigation Launched: Berman Tabacco announces an investigation into SelectQuote for allegedly receiving illegal payments from Humana and Aetna between 2016 and 2021, potentially exceeding $80 million, highlighting significant governance risks for the company.
  • Executive Involvement: The complaint alleges that senior executives at SelectQuote were personally involved in the illegal payment scheme, which, if proven true, could severely damage the company's reputation and shareholder trust, potentially leading to further legal actions.
  • Stock Price Impact: Following the Department of Justice's complaint, SelectQuote's shares fell approximately 20%, reflecting market concerns over the company's compliance and future profitability, which may lead to diminished investor confidence.
  • Board Accountability: The investigation will also examine whether SelectQuote's board of directors failed in their duties regarding this incident, and if found negligent, it could trigger shareholder lawsuits and further impact the company's governance structure.
Wall Street analysts forecast SLQT stock price to rise
3 Analyst Rating
Wall Street analysts forecast SLQT stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Noble Capital
Outperform
downgrade
$7 -> $5
AI Analysis
2026-02-06
Reason
Noble Capital
Price Target
$7 -> $5
AI Analysis
2026-02-06
downgrade
Outperform
Reason
Noble Capital lowered the firm's price target on SelectQuote to $5 from $7 and keeps an Outperform rating on the shares to reflect updated forecasts and heightened near-term uncertainty following the company's fiscal Q2 report.
Craig-Hallum
Buy
downgrade
$4 -> $3
2026-02-06
Reason
Craig-Hallum
Price Target
$4 -> $3
2026-02-06
downgrade
Buy
Reason
Craig-Hallum lowered the firm's price target on SelectQuote to $3 from $4 and keeps a Buy rating on the shares. The firm notes the company reported Q2 results that were modestly ahead of estimates but lowered the full year guide.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SLQT
Unlock Now

Valuation Metrics

The current forward P/E ratio for SelectQuote Inc (SLQT.N) is -6.04, compared to its 5-year average forward P/E of -10.22. For a more detailed relative valuation and DCF analysis to assess SelectQuote Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-10.22
Current PE
-6.04
Overvalued PE
19.84
Undervalued PE
-40.28

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
1.26
Current EV/EBITDA
7.65
Overvalued EV/EBITDA
54.72
Undervalued EV/EBITDA
-52.19

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.70
Current PS
0.14
Overvalued PS
1.70
Undervalued PS
-0.30

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what should I buy under 1.00 a share?
Intellectia · 344 candidates
Price: $0.10 - $1.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
ALIT logo
ALIT
Alight Inc
507.72M
UP logo
UP
Wheels Up Experience Inc
406.86M
LAB logo
LAB
Standard BioTools Inc
392.26M
GETY logo
GETY
Getty Images Holdings Inc
360.43M
BYND logo
BYND
Beyond Meat Inc
352.61M
CAN logo
CAN
Canaan Inc
345.29M
pennystocks
Intellectia · 37 candidates
Market Cap: <= 300.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Month Price Change Pct: >= $10.00
Ticker
Name
Market Cap$
top bottom
ASPN logo
ASPN
Aspen Aerogels Inc
295.88M
SLQT logo
SLQT
SelectQuote Inc
283.31M
STTK logo
STTK
Shattuck Labs Inc
280.96M
AVIR logo
AVIR
Atea Pharmaceuticals Inc
275.01M
JELD logo
JELD
JELD-WEN Holding Inc
258.00M
TYGO logo
TYGO
Tigo Energy Inc
243.42M
good penny stocks to invest in
Intellectia · 32 candidates
Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAN logo
CAN
Canaan Inc
498.64M
ORGO logo
ORGO
Organogenesis Holdings Inc
487.34M
CERS logo
CERS
Cerus Corp
485.98M
OCGN logo
OCGN
Ocugen Inc
465.36M
API logo
API
Agora Inc
402.42M
NNDM logo
NNDM
Nano Dimension Ltd
395.43M
Best stock under 3.50 that will 3x
Intellectia · 29 candidates
Market Cap: <= 2.00BPrice: <= $3.50Beta: HighRiskRevenue 5yr Cagr: >= 20Annual Eps Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
CLVT logo
CLVT
Clarivate PLC
1.86B
BITF logo
BITF
Bitfarms Ltd
1.61B
BLND logo
BLND
Blend Labs Inc
732.49M
SNDL logo
SNDL
SNDL Inc
406.85M
LCTX logo
LCTX
Lineage Cell Therapeutics Inc
382.34M
SLQT logo
SLQT
SelectQuote Inc
283.31M

Whales Holding SLQT

A
Abrams Bison Investments, L.L.C.
Holding
SLQT
-2.90%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is SelectQuote Inc (SLQT) stock price today?

The current price of SLQT is 0.6522 USD — it has decreased -1.81

What is SelectQuote Inc (SLQT)'s business?

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

What is the price predicton of SLQT Stock?

Wall Street analysts forecast SLQT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLQT is6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SelectQuote Inc (SLQT)'s revenue for the last quarter?

SelectQuote Inc revenue for the last quarter amounts to 537.10M USD, increased 11.65

What is SelectQuote Inc (SLQT)'s earnings per share (EPS) for the last quarter?

SelectQuote Inc. EPS for the last quarter amounts to 0.27 USD, decreased -10.00

How many employees does SelectQuote Inc (SLQT). have?

SelectQuote Inc (SLQT) has 1181 emplpoyees as of March 13 2026.

What is SelectQuote Inc (SLQT) market cap?

Today SLQT has the market capitalization of 114.98M USD.